Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Current Leases: 2022-2025

Historic Current Leases for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $436,000.

  • Praxis Precision Medicines' Current Leases fell 64.38% to $436,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $436,000, marking a year-over-year decrease of 64.38%. This contributed to the annual value of $1.3 million for FY2024, which is 11.81% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Current Leases of $436,000 as of Q3 2025, which was down 42.25% from $755,000 recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Current Leases registered a high of $1.3 million during Q4 2024, and its lowest value of $436,000 during Q3 2025.
  • In the last 3 years, Praxis Precision Medicines' Current Leases had a median value of $1.1 million in 2023 and averaged $1.0 million.
  • In the last 5 years, Praxis Precision Medicines' Current Leases climbed by 12.12% in 2023 and then tumbled by 64.38% in 2025.
  • Over the past 4 years, Praxis Precision Medicines' Current Leases (Quarterly) stood at $1.0 million in 2022, then rose by 12.04% to $1.1 million in 2023, then rose by 11.81% to $1.3 million in 2024, then tumbled by 64.38% to $436,000 in 2025.
  • Its Current Leases was $436,000 in Q3 2025, compared to $755,000 in Q2 2025 and $1.1 million in Q1 2025.